Histogen Inc. (HSTO) Stock Analysis
DELISTED 2024
What happened to Histogen Inc. (HSTO) stock?
Histogen Inc. (HSTO) no longer trades on public markets. It was delisted in November 2024. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- November 2024
- Last recorded price (historical):
- $0.02 (last quote on record before the November 2024 delisting; historical, not a current quote)
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Histogen Inc. (HSTO). Histogen Inc. is a clinical-stage biotechnology company developing proprietary hypoxia-generated growth factor technology and stem cell-free biologic products. Its pipeline includes candidates for articular cartilage defects, spinal disc repair, COVID-19, and inflammation-mediated diseases.
Last analyzed: Jun 14, 2026Histogen Inc. (HSTO) Healthcare & Pipeline Overview
More about this archive record
Can I still buy HSTO shares?
No. HSTO stopped trading on public markets in November 2024, so the shares are not available through a broker. Anything you see quoted for HSTO elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before HSTO stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Histogen Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.